CymaBay Therapeutics (CBAY) Announces Clinically Meaningful Data from MBX-8025 Phase 2 in HoFH
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
Go back to CymaBay Therapeutics (CBAY) Announces Clinically Meaningful Data from MBX-8025 Phase 2 in HoFH
March 17, 2016 4:30 PM EDT
CymaBay Therapeutics (NASDAQ: CBAY) to Resume Trading at 4:30 PM ET
...
More